RenovoRx, Inc. (RNXT)
Score window: Apr. 14, 2025 to Apr. 13, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 28, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of RenovoRx, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes that the responsibility for the accuracy … | Read Filing EDGAR |
| Aug. 13, 2025 | CORRESP | Concern from SEC | Moderate | RenovoRx, Inc. submitted a response to the SEC's comment letter regarding their Form 10-K and Form 10-Q filings. The SEC raised concerns about the company's internal control over … | Read Filing EDGAR |
| Jul. 29, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed RenovoRx, Inc.'s response to their previous comments regarding the company's Form 10-K and Form 10-Q filings. They have identified issues related to the manag… | Read Filing EDGAR |
| Jul. 18, 2025 | CORRESP | Concern from SEC | Moderate | RenovoRx, Inc. submitted a response to the SEC's comment letter regarding their Form 10-K and Form 10-Q filings. The SEC raised concerns about the absence of a management assessme… | Read Filing EDGAR |
| Jul. 10, 2025 | UPLOAD | Concern from SEC | High | The SEC has conducted a limited review of RenovoRx, Inc.'s recent filings, specifically focusing on the financial statements and related disclosures. They have raised concerns reg… | Read Filing EDGAR |